Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis

Current Biomarker Findings - United States
doi 10.2147/cbf.s29208
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Diffuse Large B-Cell Lymphoma

2020English

Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Diffuse Large B-Cell Lymphoma: Using Immune Biomarkers to Define Novel Therapies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma

American Journal of Hematology
Hematology
2017English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy